Longevity Biotech

Longevity Biotech

Longevity Biotech

Longevity Biotech is a preclinical pharmaceutical company developing breakthrough therapeutics to treat cancer, diabetes, HIV, pulmonary hypertension and parkinson's disease.
Founded
2010
Raised
$350k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$350,000
Grant - 2012
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Longevity Biotech makes some noise.